UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
|
|
|
(State or other jurisdiction | (Commission | (IRS Employer |
of incorporation) | File Number) | Identification No.) |
(Address of principal executive offices) (ZIP Code)
Registrant’s telephone number, including area code: (
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbols | Name of each exchange on which registered | ||
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b -2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 8.01 Other Events.
As previously disclosed by Flora Growth Corp. (the "Company") on its Current Report on Form 8-K, filed with the United States Securities and Exchange Commission on May 6, 2024, the Company's board of directors (the "Board") appointed Brendan Cahill as an independent director and member of each of the Company's audit committee, compensation committee and nominating and corporate governance committee, effective May 2, 2024. As a result of Mr. Cahill's appointment to the Board and its audit committee, on May 6, 2024, the Company received a letter from The Nasdaq Stock Market LLC stating that the Company has regained compliance with the independent director and audit committee requirements for continued listing on The Nasdaq Capital Market set forth in Nasdaq Listing Rules 5605(b)(1) and 5605(c)(2) and that the matter is now closed.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
104 | Cover Page Interactive Data File |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
FLORA GROWTH CORP. | |||
Date: May 7, 2024 | By: | /s/ Clifford Starke | |
Name: | Clifford Starke | ||
Title: | Chief Executive Officer |
Document and Entity Information Document |
May 06, 2024 |
---|---|
Document Information [Line Items] | |
Document Type | 8-K |
Document Creation Date | May 06, 2024 |
Document Period End Date | May 06, 2024 |
Amendment Flag | false |
Entity Registrant Name | Flora Growth Corp. |
Entity Address, Address Line One | 3230 W. Commercial Boulevard, Suite 180 |
Entity Address, City or Town | Fort Lauderdale |
Entity Address, State or Province | FL |
Entity Address, Country | US |
Entity Address, Postal Zip Code | 33309 |
Entity Incorporation, State Country Name | A6 |
City Area Code | 954 |
Local Phone Number | 842-4989 |
Entity File Number | 001-40397 |
Entity Central Index Key | 0001790169 |
Entity Emerging Growth Company | true |
Entity Tax Identification Number | 00-0000000 |
Entity Ex Transition Period | false |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Shares, no par value |
Trading Symbol | FLGC |
Security Exchange Name | NASDAQ |
QJ?=ND!4!J-2BTUPF)%V5M;
M8O/Q28<2DV)I%5QHH\'[CPR;.KU1-H&K7PC\C=\5V
MD53+C?I5=-QOZ3^#H11DE$86WC\]]KX<3DT#B ,9LD'](M>"TF